II
Ishara Investments Portfolio holdings
AUM
$85.9M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$85.9M
AUM Growth
–
Holding
38
Top Buys
| 1 | +$7.45M | |
| 2 | +$6.3M | |
| 3 | +$5.44M | |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$3.82M |
| 5 |
Amicus Therapeutics
FOLD
|
+$3.54M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 97.8% |
| 2 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ultragenyx Pharmaceutical
RARE
$2.21B
| $1.15M | 1.34% |
+50,000
|
|
||
27
Ascendis Pharma
ASND
$14B
| $1.07M | 1.24% |
+5,000
|
|
||
28
NewAmsterdam Pharma
NAMS
$4.03B
| $1.05M | 1.22% |
+30,000
|
|
||
29
Lexicon Pharmaceuticals
LXRX
$627M
| $1.01M | 1.18% |
+880,000
|
|
||
30
Biohaven
BHVN
$1.53B
| $994K | 1.16% |
+88,000
|
|
||
31
Dianthus Therapeutics
DNTH
$2.24B
| $989K | 1.15% |
+24,000
|
|
||
32
Nektar Therapeutics
NKTR
$1.97B
| $846K | 0.98% |
+20,000
|
|
||
33
Immatics
IMTX
$1.38B
| $840K | 0.98% |
+80,000
|
|
||
34
Agios Pharmaceuticals
AGIO
$1.76B
| $817K | 0.95% |
+30,000
|
|
||
35
Immunovant
IMVT
$5.54B
| $763K | 0.89% |
+30,000
|
|
||
36
Olema Pharmaceuticals
OLMA
$1.93B
| $750K | 0.87% |
+30,000
|
|
||
37
Arcutis Biotherapeutics
ARQT
$3.31B
| $348K | 0.41% |
+12,000
|
|
||
38
Corcept Therapeutics
CORT
$3.81B
| – | – |
0
|
|